ACTIVE SUBSTANCE / INN

ISATUXIMAB-IRFC

Brand name(s): SARCLISA
FDA LISTED
PRESCRIPTION
BLA761113
ACTIVE SUBSTANCE
Isatuximab-Irfc
REGULATORS
FDA
SPONSORS / MAH
SANOFI AVENTIS US
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SARCLISABLA761113SANOFI AVENTIS USPrescription

FULL INTELLIGENCE ON ISATUXIMAB-IRFC

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →